LuinaBio is Australia’s most experienced biopharmaceutical CDMO’s with 20 years’ experience in our field. More specifically Luina carries out microbial aerobic and anaerobic fermentation, yeast fermentation, cell banking, vaccine production, process development, analytical services, stability studies, storage and distribution of investigative material for clinical studies.
Quay Pharmaceuticals is a privately owned CDMO working from FDA and MHRA inspected facilities. We are licensed to formulate and manufacture the finished dosage forms for live biotherapeutics as well as small and large molecules. In the live biotherapeutic space we work with consortia and single strains for drug delivery in oral and topical formats.
Working as part of your team we rapidly and effectively bring products through development to First In Human studies to deliver success.
CosmosID®, based in Rockville, MD, provides award-winning Next-Generation Sequencing & Bioinformatics solutions for unlocking the microbiome through rapid identification and characterization of microorganisms for pharmaceutical R&D, molecular diagnostics, public health, food safety, agriculture, and environmental applications. CosmosID’s CLIA-certified laboratories offer end-to-end solutions; from study design to sample collection, extraction, library preparation, sequencing, data analysis and publication support. Lastly, CosmosID’s user-friendly and independently validated cloud-based application returns strain-level metagenomic analyses with industry leading sensitivity & precision along with access to the world’s largest database for microbial genomics.
PerkinElmer is a global leader committed to “together solving tomorrow”. Our dedicated, experienced team worldwide assist customers to solve critical issues impacting the Diagnostics, Life Sciences, Food and Applied Markets.
PerkinElmer offers instruments, reagents, assay platforms and software to hospitals, medical labs and research professionals. Together we can help you advance innovation in genomics research, offering automation solutions and a comprehensive genomics portfolio focussed towards unravelling the complexity of the metagenome in humans and agriculture.
Characterize un-culturable organisms. Discover entirely new viruses. Implement outbreak control. Monitor host-pathogen interactions. Uncovering microbiome from human and environment. Illumina technology enables you to see the bigger picture by examining the smallest details in the tiniest organisms with Next Generation Sequencing (NGS). The scale of data delivered by Illumina sequencing systems supports a broad range of microbiome research, specifically with various NGS applications available, from 16s rRNA, shotgun metagenomic to metatranscriptomic sequencing. With the robust Nextera library preparation kit and the user-friendly BaseSpace Informatics Suite, Illumina provides flexible, accurate and reliable options for microbiome research.
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951 by pharmacists and microbiologists, Biose Industrie has been manufacturing drug substance and drug products based on microorganisms for 60 years. Company, with 10 000m² of GMP facilty, offers product development at laboratory and pilot scale specialised in microbiology for aerobie and anaerobie strains and is Drug GMP certified for the manufacturing of API, clinical batches and commercial products.